Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Current Assets of $3.2 billion for Q2 2026, down 4.29% on a QoQ basis from $3.3 billion in Q1 2026, and little changed year-over-year from $3.2 billion in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Current Assets for 18 years, with the latest figure at $3.2 billion in Q2 2026.

  • On a quarterly basis, Current Assets changed 0.26% year-over-year to $3.2 billion in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 0.26% change from a year earlier, with the FY2026 full-year figure at $3.2 billion, up 9.94% from the prior year.
  • Current Assets was $3.2 billion for Q2 2026 at Dr Reddys Laboratories, down from $3.3 billion in the prior quarter.
  • The five-year high for Current Assets was $3.3 billion in Q4 2025, with the low at $2.2 billion in Q3 2022.
  • Average Current Assets over 5 years is $2.8 billion, with a median of $2.9 billion recorded in 2025.
  • The sharpest annual moves came in 2024 and 2025: Current Assets increased 26.09% in 2024, then fell 3.3% in 2025.
  • Over 5 years, Current Assets stood at $2.4 billion in 2022, then advanced by 20.91% to $2.9 billion in 2023, then climbed by 4.63% to $3.0 billion in 2024, then increased by 11.5% to $3.3 billion in 2025, then slipped by 5.37% to $3.2 billion in 2026.
  • The last three Current Assets figures came in at $3.2 billion (Q2 2026), $3.3 billion (Q1 2026), and $3.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 13.76 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 10.06 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 3.16 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 1.95 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 6.52 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 544.97 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 825.43 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 630.95 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 72.50 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 6.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.16 Bn
Mar 31, 2026 3.30 Bn
Dec 31, 2025 3.34 Bn
Sep 30, 2025 3.20 Bn
Jun 30, 2025 3.15 Bn
Mar 31, 2025 2.89 Bn
Dec 31, 2024 3.00 Bn
Sep 30, 2024 2.96 Bn
Jun 30, 2024 3.23 Bn
Mar 31, 2024 2.99 Bn
Dec 31, 2023 2.86 Bn
Sep 30, 2023 2.63 Bn
Jun 30, 2023 2.56 Bn
Mar 31, 2023 2.48 Bn
Dec 31, 2022 2.37 Bn
Sep 30, 2022 2.20 Bn
Jun 30, 2022 2.33 Bn
Mar 31, 2022 2.42 Bn
Dec 31, 2021 2.23 Bn
Sep 30, 2021 2.20 Bn